CLINICAL_TRIALS
trial_result
· 2024-05-16
Clinical Trial Update: Soy Isoflavones and Breast Cancer Risk Reduction [Phase 2]
Summary
A Phase 2 clinical trial evaluating whether soy isoflavones can reduce breast cancer risk has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-05-16